CPS Research

What CPS Research does

CPS Research, now operating under the brand FutureMeds, is a UK-headquartered private clinical research organization providing bespoke clinical trial solutions to pharmaceutical and biotech sponsors across multiple therapeutic areas. The company was founded in 1988 (firmographics) — though the FutureMeds entity references a 2001 origin — and operates a network of dedicated study sites across 10+ European countries including the United Kingdom, Germany, Spain, Poland, Bulgaria, and Ukraine, with 19 listed office locations spanning London, Newcastle, Glasgow, Teesside, Liverpool, Birmingham, Berlin, Offenbach, Madrid, Sevilla, Cadiz, Olsztyn, Wroclaw, Warsaw, Targówek, Lodz, Kraków, Zhytomyr, and Sofia. The company has conducted 2,170+ studies and enrolls 28K+ participants weekly across its network, covering nine therapy areas spanning bladder/reproductive health, muscles/nerves/pain, lungs/respiratory, digestion/metabolism, immune/vaccinations, heart/circulation, head/psyche, bones/joints, and skin/hair.

The core product is end-to-end clinical trial conduct services — patient recruitment, enrollment, and site-based study execution for Phase I-IV trials. The underlying technology is a clinical research site network platform that supports a self-serve online Trial Finder enabling patients to register interest and be screened via phone or video consultation before site visits. Revenue is generated through professional services contracts with pharmaceutical and biotech sponsors; patient participation is free, with costs covered by sponsors. Go-to-market operates patient-facing through a multi-channel content and referral approach, and sponsor-facing through a separate business domain (futuremeds.com). Pricing is not publicly disclosed.

The company employs 11-50 staff and is independently owned with no disclosed venture capital, private equity, or parent company relationships. Leadership references Alan G Wade as a director and co-founder. No API, SDK, or third-party integrations are exposed; no AI/ML capabilities are disclosed; no patents, regulatory actions, or M&A activity are reported in the source data.

Name

CPS Research

Legal name

FutureMeds

Website

https://cpsresearch.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

CPS Research (operating as FutureMeds) is a UK-based private clinical research organization operating 19 study sites across 10+ European countries, recruiting and enrolling patients for Phase I-IV clinical trials on behalf of pharmaceutical and biotech sponsors across nine therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Investigator & Site Training / GCP Support (HLAGACAF), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Clinical trial services
• Clinical research organization
• Patient recruitment
• Clinical site network
• Clinical study management

Headquarters

HQ city

Glasgow

HQ country

United Kingdom

HQ region

Europe

Offices19 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Conduct Services: FutureMeds generates revenue by conducting clinical trials on behalf of pharmaceutical and biotech sponsors. The company operates study sites and recruits/enrolls participants for Phase I-IV clinical studies across multiple therapeutic areas.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

CPS Research provides bespoke clinical trial solutions across multiple therapeutic areas. The company operates a network of clinical research sites in 10+ European countries, recruiting and enrolling participants for Phase I-IV clinical studies on behalf of pharmaceutical and biotech sponsors. Patients access trials via an online trial finder and on-site enrollment, while sponsors receive trial conduct services spanning bladder/reproductive health, muscles/nerves/pain, lungs/respiratory, stomach/digestion/metabolism, immune system/vaccinations, heart/blood circulation, head/psyche, bones/joints, and skin/hair.

Product overview

FutureMeds operates as a clinical research organization offering clinical trial services. The company provides access to clinical trials across multiple therapy areas through its network of study sites in the UK, Germany, Poland, Spain, Bulgaria, and Ukraine.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services Clinical trial recruitment, management, and participant support services enabling patients to access experimental treatments and contributing to medical research. The service covers Phase I-IV studies across therapeutic areas including bladder and reproductive health, muscles, nerves and pain, lungs and respiratory, stomach, digestion and metabolism, immune system and vaccinations, heart and blood circulation, head and psyche, bones and joints, and skin and hair. Delivered through a network of clinical research sites in 10+ European countries (UK, Germany, Spain, Poland, Bulgaria, Ukraine) on behalf of pharmaceutical and biotech sponsors.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-sized full-service CRO running multi-therapeutic global trials; comparable to FutureMeds in operating model but with deeper therapeutic specialization and US-centric footprint.
• ICON plc: Global CRO offering full-service clinical development including site management and patient recruitment — directly comparable service mix to FutureMeds but at vastly greater scale and geographic reach.
• Parexel: Large global CRO offering biopharmaceutical services including site conduct and patient recruitment; competes for the same European trial volume as FutureMeds.
• IQVIA: Largest global CRO with significant dedicated clinical-site operations and proprietary patient-recruitment assets; competes with FutureMeds for multi-country Phase II/IV trial placements.
• Labcorp Drug Development (Covance): Integrated CRO and central laboratory services provider with extensive global site network; comparable on multi-service clinical research delivery to FutureMeds.

Regional players

• Linear Clinical Research: Australia-based dedicated-site early-phase clinical research organization; comparable dedicated-site model to FutureMeds but operates in a non-overlapping geography.

Direct peers

• Catalyst Clinical Research: Independent CRO providing clinical trial services across multiple therapeutic areas; comparable in mid-size CRO positioning to FutureMeds.
• Hammersmith Medicines Research: UK-based clinical research organization operating dedicated study sites for early-phase trials; closely comparable to FutureMeds' UK-anchored dedicated site-network model.
• Worldwide Clinical Trials: Mid-sized global CRO focused on complex Phase II/III trials across multiple therapeutic areas; directly comparable in scope and customer type to FutureMeds' clinical trial services.
• Richmond Pharmacology: UK-based CRO running early-phase clinical trials at dedicated London site; comparable to FutureMeds in dedicated-site operating model and UK sponsor client base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cps_research

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CPS Research